6 articles
Retatrutide explained in depth: how GLP-1, GIP, and glucagon receptor agonism work together, what the phase 2 and phase 3 trial data actually shows, who is a clinical candidate, and what monitoring is required.
Ipamorelin and CJC-1295 in Thailand: how this growth hormone peptide combination works, the difference between CJC-1295 with and without DAC, realistic benefits and timelines for sleep, recovery, and body composition, side effects, what to monitor, and clinical-grade sourcing.
Retatrutide in Thailand: what the triple-agonist (GLP-1/GIP/glucagon) is, what the trial data shows, how it compares to semaglutide and tirzepatide, its availability and legal status, side effects to monitor, and why doctor-supervised, clinical-grade use matters.
Semax vs Selank in Thailand: how each cognitive peptide works in plain language, where they come from, the main variants, who chooses Semax for focus and Selank for calm, timelines, whether they combine, side effects, and clinical-grade sourcing.
GHK-Cu copper peptide in Thailand: how it supports skin repair signaling, collagen organisation, and tissue recovery. Clinical-grade sourcing, physician-led protocols, and responsible use explained.
Tesamorelin in Thailand: a physician-guided guide to GHRH analog therapy for visceral fat, metabolic support, and recovery. Clinical-grade sourcing, protocol design, and responsible use explained.